跳至主要内容
临床试验/NCT05209841
NCT05209841招募中不适用

Heparinization vs Salinization of the Peripheral Venous Catheter: a Randomized Clinical Trial

Consorci Sanitari de l'Alt Penedès i Garraf1 个研究点 分布在 1 个国家目标入组 3,450 人开始时间: 2022年4月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
3,450
试验地点
1
主要终点
Percentage of obstructed catheters

研究概览

简要总结

Randomized, double-blind clinical trial to compare the efficacy of catheter sealing with saline, compared to low-dose heparin. 3,450 patients hospitalized at the Hospital Residencia Sant Camil, in Catalonia (Spain), will be randomized to each branch of study. The primary outcome will be the percentage of catheters removed due to obstruction in each branch of study. As secondary outcomes, the number of catheter-associated phlebitis, catheter-associated bacetrihemia, extravasation, and catheter loss will be measured. For the primary outcome, a superiority analysis will be carried out in terms of the percentage of obstructed catheters in each branch of the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 18 yo, admitted to the Hospital Residencia Sant Camil
  • Patients with at least one peripheral venous line for discontinuous treatment, which has not been channeled in a medical emergency situation.
  • Written informed consent

排除标准

  • Allergy to heparin
  • Patients treated with unfractionated sodium heparin.
  • Patients in dialysis
  • Patients with a venous catheter indicated for diagnosis tests.
  • Patients with a venous catheter indicated for blood transfusion
  • Severe heparin-induced thrombocytopenia in recent months
  • Active uncontrollable bleeding during admission
  • Brain aneurysm or dissecting aorta, except in association with corrective surgery.
  • Confirmed / suspected cerebrovascular hemorrhage
  • Severe uncontrolled hypertension
  • Severe alterations in platelet coagulation <30,000, TP> 1.7 APTT ratio> 1.7 ratio.
  • Patient included in another clinical trial with drugs or procedures that may affect the patency of venous catheters.

研究组 & 干预措施

Catheter sealing with low dose heparin

Experimental

Catheters will be sealed with 3mL of Fibrillin Ⓡ (heparin 20UI/mL)

干预措施: Low dose heparin (Drug)

Catheter sealing with normal saline

Active Comparator

Catheters will be sealed with 3mL of 0.9% sodium chloride

干预措施: Normal saline (Drug)

结局指标

主要结局

Percentage of obstructed catheters

时间窗: From date of randomization through the date of hospital discharge, an average of 10 days.

percentage of obstructed catheters

次要结局

  • Number of catheter-associated bacterihemia episodes(From date of randomization through the date of hospital discharge, an average of 10 days.)
  • Number of catheter loss due to extravasation(From date of randomization through the date of hospital discharge, an average of 10 days.)
  • Number of catheter-associated phlebitis(From date of randomization through the date of hospital discharge, an average of 10 days.)

研究者

发起方
Consorci Sanitari de l'Alt Penedès i Garraf
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Heparinization vs Salinization of the Peripheral... | 临床试验